Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in a research report issued on Thursday,RTT News reports. A number of other analysts have also issued reports on ALLO. Oppenheimer initiated coverage on shares of Allogene Therapeutics in a research note on Thursday, August 8th. […]
More Stories
Why Cities and Towns Pick Fireworks, Drones, or Both for Independence Day
By Nanette Holt OCALA, Fla.—To boom or not to boom? That is the question coordinators of big community events face...
Keanu Reeves to Host New Docuseries About Cadillac’s Journey to Join Formula 1 Race
By Audrey Enjoli A new docuseries hosted by actor and motorsports enthusiast Keanu Reeves will chronicle Cadillac’s journey to join...
House Passes GOP Megabill, Sending Measure to Trump’s Desk
By Joseph Lord, Nathan Worcester, Lawrence Wilson and Jackson Richman WASHINGTON—The House of Representatives on July 3 passed the One...
US Economy Adds 147,000 New Jobs, Unemployment Rate Dips to 4.1 Percent in June
By Andrew Moran The U.S. job market remained strong in June, as labor conditions continued to hold up amid economic...
Liverpool Soccer Star Diogo Jota Dies in Car Crash in Spain
By Guy Birchall Liverpool and Portugal soccer star Diogo Jota, 28, died in a car crash near Zamora in northwestern...
Adobe Lightroom Review: Features, Pricing & Top Alternatives
Professional photographers have been going gaga over the Adobe Lightroom Classic for years now. Recently, another version of the tool...